FAQ (Frequently Asked Questions)
Generic drugs are those drugs which are marketed without any patent protection. They are chemically identical to brand-name drugs as they use the same Active Pharmaceutical Ingredient (API) and they both work the same way, so basically, they also have the same risks and benefits. Moreover, both the generic and brand-name drugs meet the same standards of the FDA (The U.S. Food and Drug Administration) for it’s safety, purity, quality and potency.
The expiration of a patent removes the monopoly of the patent holder on drug sales licensing; a generic drug can be sold after the patent on the original drugs expire. Hence, any pharmaceutical company by the approval of the FDA can acquire a right on manufacturing it and purchase a chemical formula.
Yes indeed. Any generic drug modeled after a brand-name drug must work in the same way and provide the same clinical benefit as its brand-name version. This standard applies to all generic medicines. A generic drug and a brand-name drug is the same in dosage, safety, effectiveness, strength, stability and quality, as well as in the way it is taken and should be used. The FDA Generic Drugs Program conducts a rigorous review to make certain that the generic drugs meet these standard.
Nevertheless, it is also significant to note that the generic drug will slightly vary from the original in some characteristics such as the manufacturing process, flavorings, colors, taste and packaging, that do not affect the safety, performance or effectiveness of the medicine. FDA limits how much variability is acceptable.
Generic manufacturers do not have the same costs as brand-name drug companies. Unlike generic manufacturers, brand-name companies incur a large portion of their costs in manufacturing the drugs and in putting it through various research trials, and once the drug is approved by FDA, the company must invest in marketing , advertising & distribution which overall, is a very long and costly process.
Whereas, generic manufacturers compete directly on price. Since multiple generic companies are often approved to market a single product, this creates competition in the market place and eventually results in lower prices for customers.
Because of the trademark laws in the United States, generic medicines cannot look the same as the branded version. Though both the generic and the brand-name medicines share the same active ingredient, they may differ in characteristics like colors and flavorings, that do not affect the functioning, safety, or effectiveness of the medicine.
Before any new medicine, including generics, is marketed, the FDA takes several actions to ensure the safety and quality of the medicine. Also, even after the approval of the medicine, including generics, the FDA staff continually monitors to make certain the medicines at all levels of the supply chain for the safety, effectiveness and quality of the medicine.
FDA further monitors and investigates reports of negative side effects or other reactions. And as a result necessary changes may be brought; changes such as how a product is used or manufactured.
No. Not every brand-name drug has a generic version. As you know that most of the brand-name drugs are produced and developed under patent protection which lasts for up to 20 years, so no one else can make or is allowed to sell the drug. Only after the patent on the original drug expires, other pharmaceutical companies can make or sell the generic drug provided they get the approval of the FDA.
We ship all packages with Express shipping with a minimal shipping charge, using Singapore post, India post & DHL E- Commerce (Not Express as DHL express needs prescription which we don’t have one on your behalf):
Trackable Courier Service takes 5-9 days depending on the destination of the country. The packages sent by this postal service can be tracked by the tracking number and will take a maximum of 14 days to deliver. Tracking number for EMS starts working within 2 business days after the order is shipped. Please expect delays of up to 1 and half month on delivery during pandemic time due to slow processing on each transit because of heavy back logs, less manpower etc.